The Fluid Translation of Research Into Practice Study

Critical Care, Fluid Resuscitation Clinical Trial

— Fluid-TRIPS  

Official title:

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS): An International Cross-Sectional Survey of Fluid Resuscitation Practice

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02002013
• Other study ID #: GI-CCT300413
• Secondary ID: ACTRN12613001172
• Status: Completed
• Phase: N/A
• First received: November 28, 2013
• Last updated: March 9, 2015
• Start date: April 2014
• Est. completion date: December 2014

Study information

• Verified date: March 2015
• Source: The George Institute for Global Health, Australia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Australia: National Health and Medical Research Council
• Study type: Observational

Clinical Trial Summary

Translating reliable evidence on fluid resuscitation of intensive care patients into clinical practice - Improving patient outcomes and containing public health costs

Description:

The Fluid-Translation of Research into Practice Study (TRIPS) is an international, single day, cross-sectional study planned for the second quarter of 2014, coordinated by the George Institute for Global Health, with the purpose of documenting prescribing practices for fluid resuscitation in intensive care units (ICUs) worldwide. This international cross-sectional study follows on from the publication of large-scale randomized controlled trials and meta-analyses of fluid resuscitation, which provide evidence of how fluid resuscitation may affect patient-centered outcomes.

Fluid-TRIPS is a repeat of the Saline versus Albumin for Fluid Evaluation (SAFE)-TRIPS which was an international cross-sectional survey conducted in 2007 that had 391 ICU's participate from 25 countries and provided insight into international fluid resuscitation practice at that time. Along with establishing if fluid resuscitation practices have changed since SAFE-TRIPS, Fluid-TRIPS also aims to determine the relationship between fluid choice and evidence, along with understand other factors that may influence the choice of bolus fluid in clinical practice.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2000
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

Adult patients present in the ICU on the study day or admitted during the 24-hour study period will be included in the study sample.

Exclusion Criteria:

Children under 16 years are excluded

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Critical Care, Fluid Resuscitation

Locations

Country	Name	City	State
Australia	The The George Institute for global health; Critical Care & Trauma Division	Sydney	New South Wales

Sponsors (1)

Lead Sponsor	Collaborator
The George Institute for Global Health, Australia

Country where clinical trial is conducted

Australia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Type of resuscitation fluid in ICU	To describe the amount and type of resuscitation fluid currently administered to adult patients in intensive care units (ICU) in different countries	24-hour study day	No
Secondary	Cost comparison of fluid choice between regions	To describe and compare the costs of fluid choice between different geographical regions	Designated 24-hour study day	No